
### [MONDO:0015121](http://purl.obolibrary.org/obo/MONDO_0015121)
**Label:** rare eye tumor

**Subclasses:** [MONDO:0008380](http://purl.obolibrary.org/obo/MONDO_0008380) (retinoblastoma), [MONDO:0011695](http://purl.obolibrary.org/obo/MONDO_0011695) (melanoma, uveal, susceptibility to, 1), [MONDO:0018885](http://purl.obolibrary.org/obo/MONDO_0018885) (orbital leiomyoma), [MONDO:0003927](http://purl.obolibrary.org/obo/MONDO_0003927) (posterior uveal melanoma), [MONDO:0008387](http://purl.obolibrary.org/obo/MONDO_0008387) (ring dermoid of cornea), [MONDO:0003745](http://purl.obolibrary.org/obo/MONDO_0003745) (choroid spindle cell melanoma), [MONDO:0018161](http://purl.obolibrary.org/obo/MONDO_0018161) (non-hereditary retinoblastoma), [MONDO:0003746](http://purl.obolibrary.org/obo/MONDO_0003746) (ciliary body spindle cell melanoma), [MONDO:0017050](http://purl.obolibrary.org/obo/MONDO_0017050) (intraocular medulloepithelioma), [MONDO:0018160](http://purl.obolibrary.org/obo/MONDO_0018160) (hereditary retinoblastoma), [MONDO:0007966](http://purl.obolibrary.org/obo/MONDO_0007966) (susceptibility to uveal melanoma), [MONDO:0004350](http://purl.obolibrary.org/obo/MONDO_0004350) (pediatric extraocular retinoblastoma), [MONDO:0011696](http://purl.obolibrary.org/obo/MONDO_0011696) (melanoma, uveal, susceptibility to, 2), [MONDO:0018607](http://purl.obolibrary.org/obo/MONDO_0018607) (combined hamartoma of the retina and retinal pigment epithelium), [MONDO:0017206](http://purl.obolibrary.org/obo/MONDO_0017206) (primary intraocular lymphoma), [MONDO:0017205](http://purl.obolibrary.org/obo/MONDO_0017205) (primary oculocerebral lymphoma), [MONDO:0003912](http://purl.obolibrary.org/obo/MONDO_0003912) (malignant ciliary body melanoma), [MONDO:0003913](http://purl.obolibrary.org/obo/MONDO_0003913) (choroid mixed cell melanoma), [MONDO:0003910](http://purl.obolibrary.org/obo/MONDO_0003910) (mixed cell uveal melanoma), [MONDO:0003878](http://purl.obolibrary.org/obo/MONDO_0003878) (malignant choroid melanoma), [MONDO:0003911](http://purl.obolibrary.org/obo/MONDO_0003911) (ciliary body mixed cell melanoma), [MONDO:0004364](http://purl.obolibrary.org/obo/MONDO_0004364) (choroid necrotic melanoma), [MONDO:0004045](http://purl.obolibrary.org/obo/MONDO_0004045) (pediatric intraocular retinoblastoma), [MONDO:0004188](http://purl.obolibrary.org/obo/MONDO_0004188) (iris spindle cell melanoma), [MONDO:0003076](http://purl.obolibrary.org/obo/MONDO_0003076) (unilateral retinoblastoma), [MONDO:0003075](http://purl.obolibrary.org/obo/MONDO_0003075) (bilateral retinoblastoma), [MONDO:0004365](http://purl.obolibrary.org/obo/MONDO_0004365) (necrotic uveal melanoma), [MONDO:0006486](http://purl.obolibrary.org/obo/MONDO_0006486) (uveal melanoma), [MONDO:0004065](http://purl.obolibrary.org/obo/MONDO_0004065) (intermediate cell type choroid melanoma), [MONDO:0006200](http://purl.obolibrary.org/obo/MONDO_0006200) (epithelioid cell uveal melanoma), [MONDO:0003078](http://purl.obolibrary.org/obo/MONDO_0003078) (extraocular retinoblastoma), [MONDO:0004066](http://purl.obolibrary.org/obo/MONDO_0004066) (intermediate cell type ciliary body melanoma), [MONDO:0003077](http://purl.obolibrary.org/obo/MONDO_0003077) (intraocular retinoblastoma), [MONDO:0004085](http://purl.obolibrary.org/obo/MONDO_0004085) (choroid epithelioid cell melanoma), [MONDO:0004063](http://purl.obolibrary.org/obo/MONDO_0004063) (intermediate cell type iris melanoma), [MONDO:0004086](http://purl.obolibrary.org/obo/MONDO_0004086) (ciliary body epithelioid cell melanoma), [MONDO:0004064](http://purl.obolibrary.org/obo/MONDO_0004064) (iris melanoma), [MONDO:0003074](http://purl.obolibrary.org/obo/MONDO_0003074) (familial retinoblastoma), [MONDO:0003073](http://purl.obolibrary.org/obo/MONDO_0003073) (trilateral retinoblastoma), [MONDO:0004062](http://purl.obolibrary.org/obo/MONDO_0004062) (intermediate cell type uveal melanoma), 

**Mapped go classes:** [GO:0003171](http://purl.obolibrary.org/obo/GO_0003171) (atrioventricular valve development), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0000976](http://purl.obolibrary.org/obo/GO_0000976) (transcription regulatory region sequence-specific DNA binding), [GO:0021554](http://purl.obolibrary.org/obo/GO_0021554) (optic nerve development), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0031076](http://purl.obolibrary.org/obo/GO_0031076) (embryonic camera-type eye development), [GO:0043114](http://purl.obolibrary.org/obo/GO_0043114) (regulation of vascular permeability), [GO:0061325](http://purl.obolibrary.org/obo/GO_0061325) (cell proliferation involved in outflow tract morphogenesis), [GO:0000981](http://purl.obolibrary.org/obo/GO_0000981) (RNA polymerase II transcription factor activity, sequence-specific DNA binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0021538](http://purl.obolibrary.org/obo/GO_0021538) (epithalamus development), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0048536](http://purl.obolibrary.org/obo/GO_0048536) (spleen development), [GO:0009653](http://purl.obolibrary.org/obo/GO_0009653) (anatomical structure morphogenesis), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0001764](http://purl.obolibrary.org/obo/GO_0001764) (neuron migration), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0048384](http://purl.obolibrary.org/obo/GO_0048384) (retinoic acid receptor signaling pathway), [GO:0043010](http://purl.obolibrary.org/obo/GO_0043010) (camera-type eye development), [GO:2000134](http://purl.obolibrary.org/obo/GO_2000134) (negative regulation of G1/S transition of mitotic cell cycle), [GO:0048382](http://purl.obolibrary.org/obo/GO_0048382) (mesendoderm development), [GO:0070986](http://purl.obolibrary.org/obo/GO_0070986) (left/right axis specification), [GO:0031290](http://purl.obolibrary.org/obo/GO_0031290) (retinal ganglion cell axon guidance), [GO:0007520](http://purl.obolibrary.org/obo/GO_0007520) (myoblast fusion), [GO:0002074](http://purl.obolibrary.org/obo/GO_0002074) (extraocular skeletal muscle development), [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0060412](http://purl.obolibrary.org/obo/GO_0060412) (ventricular septum morphogenesis), [GO:0007368](http://purl.obolibrary.org/obo/GO_0007368) (determination of left/right symmetry), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:0021763](http://purl.obolibrary.org/obo/GO_0021763) (subthalamic nucleus development), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0007519](http://purl.obolibrary.org/obo/GO_0007519) (skeletal muscle tissue development), [GO:0061072](http://purl.obolibrary.org/obo/GO_0061072) (iris morphogenesis), [GO:0035886](http://purl.obolibrary.org/obo/GO_0035886) (vascular smooth muscle cell differentiation), [GO:0048557](http://purl.obolibrary.org/obo/GO_0048557) (embryonic digestive tract morphogenesis), [GO:0008024](http://purl.obolibrary.org/obo/GO_0008024) (cyclin/CDK positive transcription elongation factor complex), [GO:0043388](http://purl.obolibrary.org/obo/GO_0043388) (positive regulation of DNA binding), [GO:0003253](http://purl.obolibrary.org/obo/GO_0003253) (cardiac neural crest cell migration involved in outflow tract morphogenesis), [GO:0001105](http://purl.obolibrary.org/obo/GO_0001105) (RNA polymerase II transcription coactivator activity), [GO:0060325](http://purl.obolibrary.org/obo/GO_0060325) (face morphogenesis), [GO:0001102](http://purl.obolibrary.org/obo/GO_0001102) (RNA polymerase II activating transcription factor binding), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0001078](http://purl.obolibrary.org/obo/GO_0001078) (transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0055123](http://purl.obolibrary.org/obo/GO_0055123) (digestive system development), [GO:0001191](http://purl.obolibrary.org/obo/GO_0001191) (transcriptional repressor activity, RNA polymerase II transcription factor binding), [GO:0016055](http://purl.obolibrary.org/obo/GO_0016055) (Wnt signaling pathway), [GO:0051726](http://purl.obolibrary.org/obo/GO_0051726) (regulation of cell cycle), [GO:0055007](http://purl.obolibrary.org/obo/GO_0055007) (cardiac muscle cell differentiation), [GO:0035116](http://purl.obolibrary.org/obo/GO_0035116) (embryonic hindlimb morphogenesis), [GO:0055009](http://purl.obolibrary.org/obo/GO_0055009) (atrial cardiac muscle tissue morphogenesis), [GO:0035993](http://purl.obolibrary.org/obo/GO_0035993) (deltoid tuberosity development), [GO:0021501](http://purl.obolibrary.org/obo/GO_0021501) (prechordal plate formation), [GO:0021986](http://purl.obolibrary.org/obo/GO_0021986) (habenula development), [GO:0021983](http://purl.obolibrary.org/obo/GO_0021983) (pituitary gland development), [GO:0009887](http://purl.obolibrary.org/obo/GO_0009887) (animal organ morphogenesis), [GO:0001085](http://purl.obolibrary.org/obo/GO_0001085) (RNA polymerase II transcription factor binding), [GO:2000288](http://purl.obolibrary.org/obo/GO_2000288) (positive regulation of myoblast proliferation), [GO:0055015](http://purl.obolibrary.org/obo/GO_0055015) (ventricular cardiac muscle cell development), [GO:0051219](http://purl.obolibrary.org/obo/GO_0051219) (phosphoprotein binding), [GO:0030334](http://purl.obolibrary.org/obo/GO_0030334) (regulation of cell migration), [GO:0035462](http://purl.obolibrary.org/obo/GO_0035462) (determination of left/right asymmetry in diencephalon), [GO:0035189](http://purl.obolibrary.org/obo/GO_0035189) (Rb-E2F complex), [GO:0061031](http://purl.obolibrary.org/obo/GO_0061031) (endodermal digestive tract morphogenesis), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0060460](http://purl.obolibrary.org/obo/GO_0060460) (left lung morphogenesis), [GO:0003350](http://purl.obolibrary.org/obo/GO_0003350) (pulmonary myocardium development), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0021855](http://purl.obolibrary.org/obo/GO_0021855) (hypothalamus cell migration), [GO:0042476](http://purl.obolibrary.org/obo/GO_0042476) (odontogenesis), [GO:0001570](http://purl.obolibrary.org/obo/GO_0001570) (vasculogenesis), [GO:0048738](http://purl.obolibrary.org/obo/GO_0048738) (cardiac muscle tissue development), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0001569](http://purl.obolibrary.org/obo/GO_0001569) (branching involved in blood vessel morphogenesis), [GO:0030324](http://purl.obolibrary.org/obo/GO_0030324) (lung development), [GO:0061386](http://purl.obolibrary.org/obo/GO_0061386) (closure of optic fissure), [GO:0031490](http://purl.obolibrary.org/obo/GO_0031490) (chromatin DNA binding), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0060971](http://purl.obolibrary.org/obo/GO_0060971) (embryonic heart tube left/right pattern formation), [GO:0071907](http://purl.obolibrary.org/obo/GO_0071907) (determination of digestive tract left/right asymmetry), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0007601](http://purl.obolibrary.org/obo/GO_0007601) (visual perception), [GO:0061303](http://purl.obolibrary.org/obo/GO_0061303) (cornea development in camera-type eye), [GO:0060577](http://purl.obolibrary.org/obo/GO_0060577) (pulmonary vein morphogenesis), [GO:0060578](http://purl.obolibrary.org/obo/GO_0060578) (superior vena cava morphogenesis), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0048593](http://purl.obolibrary.org/obo/GO_0048593) (camera-type eye morphogenesis), [GO:0048596](http://purl.obolibrary.org/obo/GO_0048596) (embryonic camera-type eye morphogenesis), 

**Class expressions from DL-Learner:**

- Thing 53.99%
- [GO:0061072](http://purl.obolibrary.org/obo/GO_0061072) (iris morphogenesis) 51.28%
- [GO:0060578](http://purl.obolibrary.org/obo/GO_0060578) (superior vena cava morphogenesis) 51.28%
- [GO:0060577](http://purl.obolibrary.org/obo/GO_0060577) (pulmonary vein morphogenesis) 51.28%
- [GO:0060460](http://purl.obolibrary.org/obo/GO_0060460) (left lung morphogenesis) 51.28%
- [GO:0060325](http://purl.obolibrary.org/obo/GO_0060325) (face morphogenesis) 51.28%
- [GO:0048705](http://purl.obolibrary.org/obo/GO_0048705) (skeletal system morphogenesis) 51.28%
- [GO:0048704](http://purl.obolibrary.org/obo/GO_0048704) (embryonic skeletal system morphogenesis) 51.28%
- [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis) 51.28%
- [GO:0048596](http://purl.obolibrary.org/obo/GO_0048596) (embryonic camera-type eye morphogenesis) 51.28%
- [GO:0048593](http://purl.obolibrary.org/obo/GO_0048593) (camera-type eye morphogenesis) 51.28%
- [GO:0048557](http://purl.obolibrary.org/obo/GO_0048557) (embryonic digestive tract morphogenesis) 51.28%
- [GO:0048048](http://purl.obolibrary.org/obo/GO_0048048) (embryonic eye morphogenesis) 51.28%
- [GO:0048592](http://purl.obolibrary.org/obo/GO_0048592) (eye morphogenesis) and [GO:0048598](http://purl.obolibrary.org/obo/GO_0048598) (embryonic morphogenesis) 51.28%
- [GO:0048562](http://purl.obolibrary.org/obo/GO_0048562) (embryonic organ morphogenesis) and [GO:0048592](http://purl.obolibrary.org/obo/GO_0048592) (eye morphogenesis) 51.28%


